HPV Vaccinations for Boys?
The Advisory Committee on Immunization Practices of the CDC is endorsing vaccinations against human papillomavirus (HPV) for boys of ages 11 and 12.
This announcement comes on the heels of new research that reportedly documents the rise in cancers caused by HPV
Research published recently in the Journal of Clinical Oncology shows HPV-16, the strain of sexually-transmitted virus that causes many cases of cervical cancer, is responsible for a significant increase in the incidence of cancers of the throat, tonsils and tongue. The study, which tested tumor samples collected between 1984 and 2004, found HPV in only 16 percent of the samples taken in the 1980s but in 72 percent of those collected after 2000.
Researchers estimate the incidence in HPV-related throat cancers in the general population increased 225 percent from 1988-2004.
The FDA currently recommends Gardasil and Cervarix for females ages 9-26 to protect against most cases of cervical cancer. Gardasil is also approved for the prevention of HPV-related vulvar and vaginal cancers. The vaccines prevent precancerous lesions caused by HPV-16 and HPV-18, the most common cancer-associated types.
The CDC committee is recommending boys ages 11-12 to also be vaccinated.
What's your stance?